Abstract:Phage-display selection of immunoglobulin (IG) or antibody single chain Fragment variable (scFv) from combinatorial libraries is widely used for identifying new antibodies for novel targets. Next-generation sequencing (NGS) has recently emerged as a new method for the high throughput characterization of IG and T cell receptor (TR) immune repertoires both in vivo and in vitro. However, challenges remain for the NGS sequencing of scFv from combinatorial libraries owing to the scFv length (>800 bp) and the presence of two variable domains [variable heavy (VH) and variable light (VL) for IG] associated by a peptide linker in a single chain. Here, we show that single-molecule real-time (SMRT) sequencing with the Pacific Biosciences RS II platform allows for the generation of full-length scFv reads obtained from an in vivo selection of scFv-phages in an animal model of atherosclerosis. We first amplified the DNA of the phagemid inserts from scFv-phages eluted from an aortic section at the third round of the in vivo selection. From this amplified DNA, 450,558 reads were obtained from 15 SMRT cells. Highly accurate circular consensus sequences from these reads were generated, filtered by quality and then analyzed by IMGT/HighV-QUEST with the functionality for scFv. Full-length scFv were identified and characterized in 348,659 reads. Full-length scFv sequencing is an absolute requirement for analyzing the associated VH and VL domains enriched during the in vivo panning rounds. In order to further validate the ability of SMRT sequencing to provide high quality, full-length scFv sequences, we tracked the reads of an scFv-phage clone P3 previously identified by biological assays and Sanger sequencing. Sixty P3 reads showed 100% identity with the full-length scFv of 767 bp, 53 of them covering the whole insert of 977 bp, which encompassed the primer sequences. The remaining seven reads were identical over a shortened length of 939 bp that excludes the vicinity of primers at both ends. Interestingly these reads were obtained from each of the 15 SMRT cells. Thus, the SMRT sequencing method and the IMGT/HighV-QUEST functionality for scFv provides a straightforward protocol for characterization of full-length scFv from combinatorial phage libraries.

Comprehensive phage display viral antibody profiling using VirScan: potential applications in chronic immune-mediated disease

Phage ImmunoPrecipitation Sequencing (PhIP-Seq): The Promise of High Throughput Serology

Virus-Derived Peptides for Clinical Applications

Deconvoluting virome-wide antibody epitope reactivity profiles

Phage immunoprecipitation and sequencing-a versatile technique for mapping the antibody reactome

High-throughput Sequencing of the Porcine Antibody Repertoire with or Without PEDV Infection: A Proof-of-concept Study.

High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable phage display

Applications of VirScan to broad serological profiling of bat reservoirs for emerging zoonoses

The Clinical Applications of Immunosequencing

Seq2scFv: a toolkit for the comprehensive analysis of display libraries from long-read sequencing platforms

Pacific Biosciences Sequencing and IMGT/HighV-QUEST Analysis of Full-Length Single Chain Fragment Variable from an In Vivo Selected Phage-Display Combinatorial Library

Simultaneous measurement of the antibody responses against SARS-CoV-2 and its multiple variants by a phage display mediated immuno-multiplex quantitative PCR-based assay

Phage Display Technology in Biomarker Identification with Emphasis on Non-Cancerous Diseases

Efficient encoding of large antigenic spaces by epitope prioritization with Dolphyn

Design and Screening of M13 Phage Display cDNA Libraries

Phage-layer interferometry: a companion diagnostic for phage therapy and a bacterial testing platform

The role of phage display in therapeutic antibody discovery

Discovery of Antivirals Using Phage Display

Large-scale interaction profiling of PDZ domains through proteomic peptide-phage display using human and viral phage peptidomes

Phage Display Technique as a Tool for Diagnosis and Antibody Selection for Coronaviruses